The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension

Current Opinion in Neurology

Volumn 24, Issue 1, 2011, Pages 12-17

  Fraser, Clare ^a   Plant, Gordon T ^b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

dural sinus stenosis; dural sinus thrombosis; intracranial hypertension; papilloedema; pseudotumour cerebri

Indexed keywords

ACETAZOLAMIDE; BENDROFLUMETHIAZIDE; FUROSEMIDE; OCTREOTIDE; TOPIRAMATE;

ARTERY COMPRESSION; BARIATRIC SURGERY; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; BRAIN PSEUDOTUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMPRESSION THERAPY; CRANIAL SINUS; DIETARY INTAKE; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; HUMAN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LIFESTYLE MODIFICATION; OBESITY; PATHOPHYSIOLOGY; PHLEBOGRAPHY; PREVALENCE; REVIEW; SINUS VENOSUS; STENT; VISUAL FIELD; WEIGHT GAIN;

ACETAZOLAMIDE; BODY MASS INDEX; CARBONIC ANHYDRASE INHIBITORS; CONSTRICTION, PATHOLOGIC; HUMANS; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE IMAGING; OBESITY; PSEUDOTUMOR CEREBRI; SYNDROME; WEIGHT LOSS;

EID: 78651405009     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328341f94a     Document Type: Review

References (44)

1. Wall M. Idiopathic intracranial hypertension. Neurol Clin 2010; 28:593-617.
2. Nonne M. Ü ber Fä lle vom Symptomenkomplex "Tumor cerebri" mit Ausgang in Heilung (Pseudotumor cerebri). Ü ber letal verlaufene Fä lle von "Pseudotumor cerebri" mit Sektionsbefund. J Neurol 1904; 27:169-216.
3. Pearce JM. From pseudotumour cerebri to idiopathic intracranial hypertension. Pract Neurol 2009; 9:353-356.
4. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59:1492-1495.
5. Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache 2009; 49:185-193.
6. Thurtell MJ, Newman NJ, Biousse V. Visual loss without papilledema in idiopathic intracranial hypertension. J Neuroophthalmol 2010; 30:96-98.
7. Wilkes BN, Siatkowski RM. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. J Neuroophthalmol 2009; 29:281-283.
8. Ney JJ, Volpe NJ, Liu GT, et al. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology 2009; 116:1808-1813e1.
9. Rebolleda G, Munoz-Negrete FJ. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci 2009; 50:5197-5200.
10. De Simone R, Ranieri A, Bonavita V. Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis. Neurol Sci 2010; 31 (Suppl 1):S33-S39.
11. Santos-Lasaosa S, Martinez-Martinez M, Lopez Del Val LJ, Perez-Lazaro C. Incidence of venous system disease in pseudotumor cerebri. Neurologia 2009; 24:462-464.
12. Connor SE, Siddiqui MA, Stewart VR, O'Flynn EA. The relationship of transverse sinus stenosis to bony groove dimensions provides an insight into the aetiology of idiopathic intracranial hypertension. Neuroradiology 2008; 50:999-1004.
13. Strydom MA, Briers N, Bosman MC, Steyn S. The anatomical basis of venographic filling defects of the transverse sinus. Clin Anat 2010; 23:153-159.
14. Zheng HB, Zhou M, Zhao B, et al. Pseudotumor cerebri syndrome and giant arachnoid granulation: treatment with venous sinus stenting. J Vasc Interv Radiol 2010; 21:927-929.
15. Lee SW, Gates P, Morris P, et al. Idiopathic intracranial hypertension; immediate resolution of venous sinus 'obstruction' after reducing cerebrospinal fluid pressure to
16. Bussiere M, Falero R, Nicolle D, et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2010; 31:645-650.
17. Arac A, Lee M, Steinberg GK, et al. Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus 2009; 27:E14.
18. Nedelmann M, Kaps M, Mueller-Forell W. Venous obstruction and jugular valve insufficiency in idiopathic intracranial hypertension. J Neurol 2009; 256:964-969.
19. Kesler A, Kliper E, Shenkerman G, Stern N. Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology 2010; 117:169-174.
20. Hannerz J, Ericson K. The relationship between idiopathic intracranial hypertension and obesity. Headache 2009; 49:178-184.
21. Kim TW, Choung HK, Khwarg SI, et al. Obesity may not be a risk factor for idiopathic intracranial hypertension in Asians. Eur J Neurol 2008; 15:876-879.
22. Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand 2010; 121:71-82.
23. Sinclair AJ, Ball AK, Burdon MA, et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol 2008; 201-202:212-220.
24. Ball AK, Sinclair AJ, Curnow SJ, et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) 2009; 70:863-869.
25. Dhungana S, Sharrack B, Woodroofe N. Cytokines and chemokines in idiopathic intracranial hypertension. Headache 2009; 49:282-285.
26. Skau M, Goetze JP, Rehfeld JF, Jensen R. Natriuretic pro-peptides in idiopathic intracranial hypertension. Regul Pept 2010; 164:71-77.
27. Dhungana S, Waters P, Ismail A, et al. Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. J Neurol 2010; 257:1211-1212.
28. Kesler A, Kliper E, Assayag EB, et al. Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis 2010; 21:328-333.
29. Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. Br Med J 2010; 341:c2701.
30. Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs. acetazolamide, an open-label study. Acta Neurol Scand 2007; 116:322-327.
31. Marmura MJ, Hopkins M, Andrel J, et al. Electronic medical records as a research tool: evaluating topiramate use at a headache center. Headache 2010; 50:769-778.
32. Panagopoulos GN, Deftereos SN, Tagaris GA, et al. Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci 2007; 1.
33. Uretsky S. Surgical interventions for idiopathic intracranial hypertension. Curr Opin Ophthalmol 2009; 20:451-455.
34. Toma AK, Dherijha M, Kitchen ND, Watkins LD. Use of lumboperitoneal shunts with the Strata NSC valve: a single-centre experience. J Neurosurg .2010. [Epub ahead of print].
35. Ulivieri S, Oliveri G, Georgantzinou M, et al. Long-term effectiveness of lumboperitoneal flow-regulated shunt system for idiopathic intracranial hypertension. J Neurosurg Sci 2009; 53:107-111.
36. Udayakumaran S, Roth J, Kesler A, Constantini S. Miethke DualSwitch valve in lumboperitoneal shunts. Acta Neurochir (Wien) 2010; 152:1793-1800.
37. Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg 2010 [Epub ahead of print].
38. Mollan SP, Ball AK, Sinclair AJ, et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol 2009; 62:105-108.
39. Agarwal P, Kumar M, Arora V. Clinical profile of cerebral venous sinus thrombosis and the role of imaging in its diagnosis in patients with presumed idiopathic intracranial hypertension. Indian J Ophthalmol 2010; 58:153-155.
40. Kiehna E, Keil M, Lodish M, et al. Pseudotumour cerebri after surgical remission of Cushing's disease. J Clin Endocrinol Metab 2010; 95:1528-1532.
41. Essaadouni L, Jaafari H, Abouzaid CH, Kissani N. Neurological involvement in Behcet's disease: evaluation of 67 patients. Rev Neurol (Paris) 2010; 166:727-733.
42. Barahona-Hernando R, Rios-Blanco JJ, Mendez-Meson I, et al. Idiopathic intracranial hypertension and systemic lupus erythematosus: a case report and review of the literature. Lupus 2009; 18:1121-1123.
43. Bababeygy S, Repka MX, Subramanian PS. Minocycline-associated pseudotumor cerebri with severe papilledema. J Ophthalmol 2009; 2009:203583.
44. Kapoor KG. More than meets the eye? Redefining idiopathic intracranial hypertension. Int J Neurosci 2010; 120:471-482.